1-4 of 4
Graham Phillip Taylor
Close
Sort by
Journal Articles

Anti-T Cell Receptor Vβ Chain-Specific CAR-iNKT Cells As a Precise Strategy to Treat Mature T Cell Lymphomas

Aileen G Rowan, Kanagaraju Ponnusamy, Hongwei Ren, Graham Phillip Taylor, Lucy Cook, Anastasios Karadimitris
Journal: Blood
Blood (2022) 140 (Supplement 1): 10257–10258.
https://doi.org/10.1182/blood-2022-165271
Published: 2022
Journal Articles

HTLV-1 Carriers with Circulating Dominant Clones Harbor ATL-like Mutational and Transcriptomic Profiles Which Identify an Ultra-High Risk Group for Disease Transformation

Sonia N Wolf, Patricia Watber, Jana Haddow, Clare Greiller, Graham Phillip Taylor, Lucy Cook, Aileen G Rowan
Journal: Blood
Blood (2022) 140 (Supplement 1): 9224–9225.
https://doi.org/10.1182/blood-2022-159709
Published: 2022
Journal Articles

Transcriptome and Somatic Mutation Associated with Non-Malignant Human T Lymphotropic Virus Type 1 Infection and Adult T-Cell Leukemia/Lymphoma

Huseini Hatimbhai Kagdi, MD PhD MBBS, FRCPath, MRCP, Graham Phillip Taylor, MB ChB, DSc, FRCP, FHEA
Journal: Blood
Blood (2018) 132 (Supplement 1): 2843.
https://doi.org/10.1182/blood-2018-99-111167
Published: 2018
Journal Articles

The In Vivo infected Clones Have Mixed Immunophenotype and Malignant Transformation Is Characterized By Dominant Growth of CD4+CCR4+CD26-CD7- Cells in Human T Lymphotropic Virus Type 1 Infection

Huseini Hatimbhai Kagdi, MD PhD MBBS, FRCPath, MRCP, Graham Phillip Taylor, MB ChB, DSc, FRCP, FHEA
Journal: Blood
Blood (2018) 132 (Supplement 1): 2844.
https://doi.org/10.1182/blood-2018-99-111440
Published: 2018